CIK 0001764013
- Large accelerated filer
Immunovant, Inc.
Sign in to watch- Ticker
- IMVT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 832771572
- Phone
- +1 917-410-3120
- Business address
- 1000 PARK FORTY PLAZA, DURHAM, NC, 27713
- Former names
- Health Sciences Acquisitions Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $895,852
- in 9 filings, $173K under 10b5-1 plans
Net −$895,852. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-02 | Roivant Sciences Ltd. Director | Grant or award | +4,473,684 | $38.00 | $170.0M | 78,279,015 |
| 2023-10-02 | Roivant Sciences Ltd. Director | Purchase | +1,526,316 | $38.00 | $58.0M | 79,805,331 |
| 2023-08-30 | Salzmann Peter Chief Executive Officer | Sale | −50,866 | $21.97 | $1.1M | 975,873 |
| 2023-08-30 | Salzmann Peter Chief Executive Officer | Sale | −5,908 | $22.48 | $133K | 969,965 |
| 2023-08-24 | Levine Mark S. Chief Legal Officer | Sale | −12,285 | $20.30 | $249K | 314,489 |
| 2023-08-24 | Levine Mark S. Chief Legal Officer | Sale | −1 | $20.89 | $21 | 314,488 |
| 2023-08-24 | Barnett Eva Renee Chief Financial Officer | Sale | −14,385 | $20.30 | $292K | 335,478 |
| 2023-08-24 | Barnett Eva Renee Chief Financial Officer | Sale | −1 | $20.89 | $21 | 335,477 |
| 2023-08-24 | Butchko Julia G. Chief Development Officer | Sale | −12,332 | $20.30 | $250K | 416,261 |
| 2023-08-24 | Butchko Julia G. Chief Development Officer | Sale | −1 | $20.89 | $21 | 416,260 |
| 2023-08-24 | Macias William L. Chief Medical Officer | Sale | −12,332 | $20.30 | $250K | 337,393 |
| 2023-08-24 | Macias William L. Chief Medical Officer | Sale | −1 | $20.89 | $21 | 337,392 |
| 2023-08-14 | Salzmann Peter Chief Executive Officer | Sale | −91,744 | $21.34 | $2.0M | 1,038,053 |
| 2023-08-14 | Salzmann Peter Chief Executive Officer | Sale | −11,314 | $22.04 | $249K | 1,026,739 |
| 2023-08-07 | Salzmann Peter Chief Executive Officer | Sale | −101,339 | $21.73 | $2.2M | 1,129,797 |
| 2023-07-26 | Levine Mark S. Chief Legal Officer | Sale | −3,917 | $21.63 | $85K | 326,774 |
| 2023-07-19 | Macias William L. Chief Medical Officer | Sale | −426 | $24.94 | $11K | 349,725 |
| 2023-07-19 | Barnett Eva Renee Chief Financial Officer | Sale | −2,725 | $24.94 | $68K | 349,863 |
| 2023-07-12 | Salzmann Peter Chief Executive Officer | Sale | −3,233 | $19.73 | $64K | 1,231,136 |
| 2023-07-12 | Butchko Julia G. Chief Development Officer | Sale | −1,470 | $19.73 | $29K | 428,593 |
Page 17 of 18 · 351 trades